Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients
R. L. Dobbins, R. O’Connor-Semmes, A. Kapur, C. Kapitza, G. Golor, I. Mikoshiba, W. Tao, E. K. HusseyVolume:
14
Year:
2012
Language:
english
Pages:
8
DOI:
10.1111/j.1463-1326.2011.01462.x
File:
PDF, 612 KB
english, 2012